BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15713801)

  • 1. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.
    Rocha JC; Cheng C; Liu W; Kishi S; Das S; Cook EH; Sandlund JT; Rubnitz J; Ribeiro R; Campana D; Pui CH; Evans WE; Relling MV
    Blood; 2005 Jun; 105(12):4752-8. PubMed ID: 15713801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?
    Hoang PT; Ambroise J; Dekairelle AF; Durant JF; Butoescu V; Chi VL; Huynh N; Nguyen TB; Robert A; Vermylen C; Gala JL
    Br J Clin Pharmacol; 2015 Mar; 79(3):429-40. PubMed ID: 25099492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia.
    Abo-Bakr A; Mossallam G; El Azhary N; Hafez H; Badawy R
    J Egypt Natl Canc Inst; 2017 Sep; 29(3):127-133. PubMed ID: 28844589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse.
    Leonardi DB; Abbate M; Riccheri MC; Nuñez M; Alfonso G; Gueron G; De Siervi A; Vazquez E; Cotignola J
    Oncotarget; 2017 Jan; 8(1):110-117. PubMed ID: 27058755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
    Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
    Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.
    Franca R; Rebora P; Bertorello N; Fagioli F; Conter V; Biondi A; Colombini A; Micalizzi C; Zecca M; Parasole R; Petruzziello F; Basso G; Putti MC; Locatelli F; d'Adamo P; Valsecchi MG; Decorti G; Rabusin M
    Pharmacogenomics J; 2017 Jan; 17(1):4-10. PubMed ID: 26644204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphism of glutathione-S-transferase M1 and T1 in children with acute lymphoblastic leukemia].
    Tsvirenko SV; Tsaur GA
    Klin Lab Diagn; 2006 Feb; (2):23-4, 33-4. PubMed ID: 16610629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
    Yang JJ; Cheng C; Yang W; Pei D; Cao X; Fan Y; Pounds SB; Neale G; Treviño LR; French D; Campana D; Downing JR; Evans WE; Pui CH; Devidas M; Bowman WP; Camitta BM; Willman CL; Davies SM; Borowitz MJ; Carroll WL; Hunger SP; Relling MV
    JAMA; 2009 Jan; 301(4):393-403. PubMed ID: 19176441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
    Anderer G; Schrappe M; Brechlin AM; Lauten M; Muti P; Welte K; Stanulla M
    Pharmacogenetics; 2000 Nov; 10(8):715-26. PubMed ID: 11186134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancestry and pharmacogenetics of antileukemic drug toxicity.
    Kishi S; Cheng C; French D; Pei D; Das S; Cook EH; Hijiya N; Rizzari C; Rosner GL; Frudakis T; Pui CH; Evans WE; Relling MV
    Blood; 2007 May; 109(10):4151-7. PubMed ID: 17264302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
    Yang JJ; Cheng C; Devidas M; Cao X; Campana D; Yang W; Fan Y; Neale G; Cox N; Scheet P; Borowitz MJ; Winick NJ; Martin PL; Bowman WP; Camitta B; Reaman GH; Carroll WL; Willman CL; Hunger SP; Evans WE; Pui CH; Loh M; Relling MV
    Blood; 2012 Nov; 120(20):4197-204. PubMed ID: 23007406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
    Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
    Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic polymorphism of GST gene in children with infectious mononucleosis and acute lymphocytic leukemia].
    Li YH; Wen FQ; Xiao ZH; Chen YX; Zhang ZX; Chen LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Apr; 14(4):260-3. PubMed ID: 22537952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
    Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
    Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
    Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
    Leukemia; 2002 Aug; 16(8):1437-42. PubMed ID: 12145682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating
    Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
    World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
    Marino S; Verzegnassi F; Tamaro P; Stocco G; Bartoli F; Decorti G; Rabusin M
    Pediatr Blood Cancer; 2009 Dec; 53(6):984-91. PubMed ID: 19621425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.